Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study-Reference-Cited by-同舟云学术

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study

Published:2023-05 Issue: Volume:59 Page:101946
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Finnigan Lucy E.M.^ORCID,Cassar Mark Philip,Koziel Margaret James,Pradines Joel,Lamlum Hanan,Azer Karim,Kirby Dan,Montgomery Hugh,Neubauer Stefan,Valkovič Ladislav,Raman Betty^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. WHO Coronavirus (COVID-19) dashboard;World Health Organization,2022

2. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021;Wulf Hanson;medRxiv,2022

3. Symptoms and signs of long COVID: a rapid review and meta-analysis;Healey;J Glob Health,2022

4. Of mitochondrion and COVID-19;Alfarouk;J Enzyme Inhib Med Chem,2021

5. Roles of host mitochondria in the development of COVID-19 pathology: could mitochondria be a potential therapeutic target?;Srinivasan;Mol Biomed,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long COVID: current management and future prospects;COVID-19: An Update;2024-09-01

2. Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection;International Journal of Molecular Sciences;2024-08-21

3. Long COVID as a disease of accelerated biological aging: An opportunity to translate geroscience interventions;Ageing Research Reviews;2024-08

4. Gaps in Long COVID treatments research: A scoping review;Wellcome Open Research;2024-07-10

5. Evaluating myelophil, a 30% ethanol extract of Astragalus membranaceus and Salvia miltiorrhiza, for alleviating fatigue in long COVID: a real-world observational study;Frontiers in Pharmacology;2024-06-20